Asteatotic eczema protein 1

Asteatotic eczema protein 1 is not a recognized biological entity or therapeutic target in medical literature. Asteatotic eczema, also known as eczema craquelé, is a common clinical condition characterized by dry, itchy, and cracked skin, primarily affecting elderly individuals due to a decrease in surface lipids and water content in the stratum corneum (PubMed: 31643444). While the pathophysiology of this condition involves the dysfunction of several key skin barrier proteins, such as Filaggrin (FLG), which is essential for the production of natural moisturizing factors, and Aquaporin-3 (AQP3), which facilitates water and glycerol transport, there is no specific protein officially designated as Asteatotic eczema protein 1 (StatPearls: NBK537131). The term appears to be a misnomer or a hallucination, as it does not correspond to any validated gene or protein in standard databases like UniProt or NCBI. Consequently, it is not considered a target for drug development, and treatments for the underlying condition typically focus on restoring the skin barrier through emollients and topical anti-inflammatory agents.